Samuel A. McMahon

Associate

Philadelphia
T +1 215.564.3297  |  F +1 215.568.3439

With a background in biochemistry, cellular and molecular biology, Samuel McMahon focuses his practice on patent prosecution in the life sciences. Conscious of client objectives and goals, he is results-driven and motivated to develop efficient solutions for client needs.

Select Experience

  • Drafted office action responses on U.S. and international patent prosecution in the life sciences space, including biotech and biomedical device applications. 
  • Drafted provisional and non-provisional patent applications for life sciences and biomedical devices.
  • Assisted inside counsel with preliminary due diligence and freedom to operate issues for both start-up and established life sciences companies.
More »

Experience

  • Drafted office action responses on U.S. and international patent prosecution in the life sciences space, including biotech and biomedical device applications. 
  • Drafted provisional and non-provisional patent applications for life sciences and biomedical devices.
  • Assisted inside counsel with preliminary due diligence and freedom to operate issues for both start-up and established life sciences companies.

Community

  • Benjamin Franklin Annual Inn of Court (2016 to 2017)
  • Philadelphia Intellectual Property Law Association (2016 to 2017)
  • Bicycle Coalition of Greater Philadelphia (2016 to 2017)

Services

Industries

Prior Positions

  • New Hampshire Supreme Court: Legal Intern (2016) 

Admissions

  • U.S. Patent and Trademark Office, Registration No. 74,865
  • Pennsylvania, 2016

Education

  • J.D., University of New Hampshire School of Law, 2016; Editor in Chief, IDEA: The Journal of The Franklin Pierce Center for Intellectual Property;Franklin Pierce Intellectual Property Law Certificate
  • M.S., Biochemistry Molecular Cellular Developmental Biology, University of California, Davis, 2013
  • B.S., M.S., Biotechnology, University of Nevada, Reno, 2009

Blog

In The Blogs

Previous Next
IP Intelligence: Insight on Intellectual Property
Requirements of § 121’s Safe Harbor: Ensuring That Divisional Applications Will Be Protected Against OTDP Rejections
By Samuel A. McMahon
February 28, 2017
In a recent decision, the Patent Trial and Appeal Board (PTAB) narrowly construed the so-called safe harbor provision of 35 U.S.C. § 121, affirming the examiner’s rejection of a patent application under the doctrine of “obviousness-type...
Read More ->
IP Intelligence: Insight on Intellectual Property
The Continuing “Evolution” of Alice: a GUI Example
By Samuel A. McMahon
January 19, 2017
On January 18, 2017, the Federal Circuit, in Trading Technologies International, Inc. v. CQG, Inc., No. 2016-1616 (Fed. Cir. Jan. 18, 2017) (NEWMAN, J.), issued a non-precedential decision affirming the district court’s holding that claims...
Read More ->
IP Intelligence: Insight on Intellectual Property
Post Grant Review: § 112 and Eligibility Issues in Chemical and Life Sciences
By Samuel A. McMahon
November 28, 2016
Post Grant Review (PGR) petitions are on the rise, and nearly half of all petitions to date have challenged patents in Biotechnology and Organic Chemistry, or Chemical and Materials Engineering technology centers.[1] We have reviewed PGR...
Read More ->
IP Intelligence: Insight on Intellectual Property
The Supreme Court Again Rejects Post-Expiration Patent Royalties
By Samuel A. McMahon
July 9, 2015
Authored by: Samuel McMahon, 2015 Summer Associate In Kimble v. Marvel Entertainment, LLC, No. 13-720 (U.S. June 22, 2015), the Supreme Court, in a 6-3 decision with Justice Kagan writing for the majority, upheld its 1964 decision in...
Read More ->